AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,764,000 | +426.6% | 116,560 | +161.0% | 0.01% | +350.0% |
| Q2 2022 | $335,000 | -17.9% | 44,653 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $408,000 | +89.8% | 44,793 | +182.0% | 0.00% | +100.0% |
| Q4 2020 | $215,000 | +14.4% | 15,885 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $188,000 | -20.3% | 16,010 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $236,000 | -47.3% | 16,010 | +5.6% | 0.00% | -50.0% |
| Q2 2019 | $448,000 | -37.8% | 15,157 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $720,000 | +39.8% | 15,157 | +81.3% | 0.00% | +33.3% |
| Q3 2018 | $515,000 | -50.6% | 8,360 | -45.8% | 0.00% | -50.0% |
| Q2 2018 | $1,042,000 | +44.5% | 15,430 | +16.1% | 0.01% | +50.0% |
| Q1 2018 | $721,000 | +161.2% | 13,290 | +134.4% | 0.00% | +100.0% |
| Q3 2017 | $276,000 | – | 5,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |